About

Our journey

From hands-on experience in the medical sector to the creation of a local pharmaceutical industry.

  • 2013

    first steps in the medical sector in West Africa

  • 2023

    SEDIS SARL becomes TILAMED PHARMA SA

  • 6

    approvals, authorisations and certificates obtained

  • 2ha

    industrial site in Sèmè-Podji

Key milestones

More than ten years in the field, an industrial ambition

2013 – 2022

The foundations

  1. 2013

    SEDIS SARL is founded

    The company is set up to supply, install and maintain medical devices in West Africa, working closely with hospitals, laboratories and procurement agencies.

  2. 2013 – 2022

    Ten years in the field, one finding

    In Benin, no injectable solution is manufactured locally. Market studies and meetings with health authorities, procurement agencies and European equipment manufacturers: the industrial project takes shape.

2023 – 2024

The authorisations

  1. 2023

    TILAMED PHARMA SA is born

    SEDIS SARL becomes TILAMED PHARMA SA, a public limited company with a share capital of one billion CFA francs, focused on industrial production.

  2. 16 May 2023

    Favourable opinion from the ABRP

    Meeting in committee, the Benin Pharmaceutical Regulatory Agency issues a favourable opinion on the opening and operation of a pharmaceutical plant.

  3. 30 June 2023

    Authorisation to install and operate

    The installation and operation of the pharmaceutical plant are authorised.

    Reference No. 1138 ABRP/DHE/DAE/SA · 30 June 2023 · Benin Pharmaceutical Regulatory Agency and Ministry of Health

  4. 7 August 2024

    Environmental and social compliance certificate

    The project is recognised as compliant with environmental and social requirements.

    Reference Order No. 0253/MCVT/DC/SGM/DG-ABE/DEES/SEIES/SA · 7 August 2024 · Ministry of Health and Ministry of the Environment

  5. 9 September 2024

    Industrial authorisation

    TILAMED Pharma's industrial activity is authorised.

    Reference No. LFFL EK3V JE3W CQ9Z · 9 September 2024 · Ministry of Trade and Industry

  6. 28 October 2024

    Technical acceptability certificate

    The list of tax-exempt production equipment is set.

    Reference No. 712/APIEX/DEAPI/SETAPI/SA · 28 October 2024 · Investment and Export Promotion Agency (APIEX)

  7. 28 November 2024

    Ministerial order

    The project is governed by ministerial order and benefits from a tax and social-security exemption (regime B, 8 years) for its investment and operating phases.

    Reference No. 034/MDC/MEF/MIC/DC/SGM/DDI/SA/041SGG24 · 28 November 2024 · Government of the Republic of Benin

2025 →

The site and the plant

  1. 9 September 2025

    The Sèmè-Podji site

    The State of Benin entrusts TILAMED PHARMA SA with a 2-hectare industrial site, under a long-term lease, in the Sèmè-Podji industrial zone on the Nigerian border.

    Reference Long-term lease No. 2494/MEF/DC/SGM/ANDF/DAJuF/DGDE/S

  2. TodayIn progress

    Building the plant

    TILAMED Pharma is preparing its injectable-solutions production unit in the Sèmè-Podji special economic zone.

  3. TomorrowNext step

    Commissioning

    Start of production and recruitment of the first teams.

What's next

Follow the construction of the plant

Every new stage of the project is announced in our news. Discover the manufacturing process of our future plant today.